ArticleDiscover oncology2022

Immune and inflammation: related factor alterations as biomarkers for predicting prognosis and responsiveness to PD-1 monoclonal antibodies in cervical cancer.

Xihan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.